Financials
- Market Capitalization 39.11 M
- Employee 16
- Founded 2013
- CEO N/A
- Website www.lanternpharma.com
- Headquarter Texas, United States
- FIGI BBG00GM6LK17
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.93
Fiyat/satışlar oranı
-390.6
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 4384 | RNXT RenovoRx, Inc. - Common Stock | 0.91 USD | -2.15% | -2.15% | +8.33% | -34.06% | 41.04 M USD | ||
| 4395 | GRCE Grace Therapeutics, Inc. - Common Stock | 2.43 USD | -0.82% | -4.33% | +10.45% | -38.94% | 39.55 M USD | ||
| 4412 | ESLA Estrella Immunopharma, Inc. - Common Stock | 0.88 USD | -6.38% | -13.73% | -20.72% | +3.53% | 37.87 M USD | ||
| 4417 | DYAI Dyadic International, Inc. - Common Stock | 1.02 USD | -3.77% | +6.25% | +43.66% | +2.00% | 37.17 M USD |